1. Sabol Z, Kipke-Sabol L. Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene. Lijec Vjesn. 2005; 127:303–11.
2. Evans GR, Lloyd SK, Ramsden RT. Neurofibromatosis type 2. Adv Otorhinolaryngol. 2011; 70:91–8.
Article
3. Boudewyns A, Claes J, Van de Heyning P. Clinical practice: an approach to stridor in infants and children. Eur J Pediatr. 2010; 169:135–41.
4. Chen YW, Fang TJ, Li HY. A solitary laryngeal neurofibroma ina pediatric patient. Chang Gung Med J. 2004; 27:930–3.
5. Shah KN. The diagnostic and clinical significance of café-au-lait macules. Pediatr Clin North Am. 2010; 57:1131–53.
Article
6. Polgár N, Komlósi K, Hadzsiev K, Illés T, Me-legh B. Molecular genetic diagnosis of neurofibromatosis type I. Orv Hetil. 2011; 152:415–9.
Article
7. Suchanek E. Neurinom des kehlkopfeinganges. Monatsschr Orhenheilkd Laryngo-Rhinol. 1925; 50:613–7.
8. Willcox TO Jr, Rosenberg SI, Handler SD. Laryngeal involvement in neurofibromatosis. Ear Nose Throat J. 1993; 72:811–2. 815.
Article
9. Masip MJ, Esteban E, Alberto C, Menor F, Cortina H. Laryngeal involvement in pediatric neurofibromatosis: a case report and review of the literature. Pediatr Radiol. 1996; 26:488–92.
Article
10. Powell S, Kubba H, O'Brien C, Tremlett M. Paediatric obstructive sleep apnoea. BMJ. 2010; 340:c1918.
11. Marcus CL, Carroll JL, Koerner CB, Hamer A, Lutz J, Loughlin GM. Determinants of growth in children with the obstructive sleep apnea syndrome. J Pediatr. 1994; 125:556–62.
Article
12. Bland RM, Bulgarelli S, Ventham JC, Jackson D, Reilly JJ, Paton JY. Total energy expenditure in children with obstructive sleep apnoea syndrome. Eur Respir J. 2001; 18:164–9.
Article
13. Amin RS, Kimball TR, Bean JA, Jeffries JL, Willging JP, Cotton RT, et al. Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med. 2002; 165:1395–9.
Article
14. Enright PL, Goodwin JL, Sherrill DL, Quan JR, Quan SF. Tucson Children's Assessment of Sleep Apnea study. Blood pressure elevation associated with sleep-related breathing disorder in a community sample of white and Hispanic children: the Tucson Children's Assessment of Sleep Apnea study. Arch Pediatr Adolesc Med. 2003; 157:901–4.
15. Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J. Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest. 2001; 119:1085–91.
16. Needle MN, Cnaan A, Dattilo J, Chatten J, Phillips PC, Shochat S, et al. Prognostic signs in the surgical management of plexiform neurofibroma: the Children's Hospital of Philadelphia experience, 1974–1994. J Pediatr. 1997; 131:678–82.
Article
17. Sidman J, Wood RE, Poole M, Postma DS. Management of plexiform neurofibroma of the larynx. Ann Otol Rhinol Laryngol. 1987; 96(1 Pt 1):53–5.
Article
18. Rahbar R, Litrovnik BG, Vargas SO, Robson CD, Nuss RC, Irons MB, et al. The biology and management of laryngeal neurofibroma. Arch Otolaryngol Head Neck Surg. 2004; 130:1400–6.
Article
19. Ransom ER, Yoon C, Manolidis S. Single stage near total resection of massive pediatric head and neck plexiform neurofibromas. Int J Pediatr Otorhinolaryngol. 2006; 70:1055–61.
Article